Alyeska Investment Group
CDLX icon

Alyeska Investment Group’s Cardlytics CDLX Stock Holding History

Alyeska Investment Group’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,199
Closed -$478K – 417
2018
Q2 		$478K Sell
2,199
-13,091
-86% -$2.42M ﹤0.01% 425
2018
Q1 		$2.24M Buy
+15,290
New +$2.59M 0.02% 341

Other funds holding CDLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SRFM
Shannon River Fund Management New York $524M AUM 90.54% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Alyeska Investment Group's CDLX Position: Q3 2018 in Review

Alyeska Investment Group sold out of Cardlytics (CDLX) in Q3 2018, closing a stake of 2,199 shares — an estimated $478K sold.

Alyeska Investment Group first reported a position in CDLX in Q1 2018 and held it in 2 quarters. The position peaked at $2.24M in Q1 2018. 58 funds tracked by Wall St. Rank hold CDLX as of Q3 2018.

  • Alyeska Investment Group reported no remaining Cardlytics position as of Q3 2018 after selling out during the quarter.
  • Alyeska Investment Group sold 2,199 Cardlytics shares in Q3 2018, an estimated $478K.
  • Alyeska Investment Group first reported a position in Cardlytics in Q1 2018 and held it in 2 quarters.
  • Alyeska Investment Group's Cardlytics position peaked at $2.24M in Q1 2018.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q3 2018.

Based on Alyeska Investment Group's 13F filing for Q3 2018, filed 14 Nov 2018.